Showing 1 - 2 results of 2 for search 'Ignacio Arístegui', query time: 0.02s
Refine Results
-
1
Cost–effectiveness of weekly gastro-resistant risedronate 35 mg, compared with weekly alendronate 70 mg tablets, in the treatment of postmenopausal osteoporosis in Spain by Enrique Casado, Jose Rosas, Carlos Rubio-Terres, Dario Rubio-Rodriguez, Mitra Boolell, Ignacio Aristegui
Published 2023-09-01Article -
2